Results 201 to 210 of about 730,939 (432)
This study provides new perspectives into the interactions between mechanical forces and cellular dynamics within the tumor microenvironment, particularly elucidating how minority Paclitaxel‐resistant cancer cells (MRCs) promote tumor progression and treatment resistance through mechanical forces and also providing effective treatment strategies for ...
Xueyan Feng+12 more
wiley +1 more source
Effect of Clinical History on Predictive Model Performance for Renal Complications of Diabetes [PDF]
Diabetes is a chronic disease characterised by a high risk of developing diabetic nephropathy, which, in turn, is the leading cause of end-stage chronic kidney disease. The early identification of individuals at heightened risk of such complications or their exacerbation can be of paramount importance to set a correct course of treatment.
arxiv
Shoshin beriberi in an AIDS patient with end‐stage renal disease [PDF]
John Bright Cage, Barry M. Wall
openalex +1 more source
The tumor microenvironment‐responsive nanoagonists are developed using an organic–inorganic copolymer composed of the polymer (PC6AB) and manganous phosphate ionic oligomers (MnP). PC6AB with membranolytic activity selectively interacts with tumor cell membranes to induce immunogenic cell death, while MnP activates the STING pathway in immune cells ...
Shiming Zhang+14 more
wiley +1 more source
Serum magnesium level and arterial calcification in end-stage renal disease
H. Erik Meema+2 more
openalex +1 more source
Apolipoprotein(a) phenotypes predict the risk for carotid atherosclerosis in patients with end-stage renal disease. [PDF]
Florian Kronenberg+8 more
openalex +1 more source
Clinical and echocardiographic disease in patients starting end-stage renal disease therapy.
R. Foley+12 more
semanticscholar +1 more source
Ovarian cancer‐derived extracellular vesicles (EVs) transfer INAVA mRNA to normal ovarian fibroblasts (NOFs). Translated INAVA protein inhibits HMGA2 phosphorylation‐dependent ubiquitylation and proteasomal degradation, promoting NOF activation.
Lingkai Gu+12 more
wiley +1 more source
The Medicare End-Stage Renal Disease Program [PDF]
Norman G. Levinsky, Richard A. Rettig
openalex +1 more source